• FirefoxUpgrade to the new Firefox »
  •  Dow Down 0.04% Nasdaq Down 0.15%

    Agenus Inc. (AGEN)

    -NasdaqCM
    4.10 Up 0.18(4.46%) 9:48AM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:3.93
    Open:4.00
    Bid:4.08 x 1600
    Ask:4.09 x 600
    1y Target Est:6.50
    Beta:2.55
    Next Earnings Date:N/A
    Day's Range:4.00 - 4.26
    52wk Range:2.27 - 5.27
    Volume:730,382
    Avg Vol (3m):435,066
    Market Cap:257.00M
    P/E (ttm):N/A
    EPS (ttm):-0.43
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    AGENUp 4.46%257.00M
    ABPIUp 16.67%314.14K
    DNDNDown 13.61%N/A

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):42.78
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.43
    Quarterly EPS Est (Dec-14) :-0.15
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Agenus Inc., a biopharmaceutical company, is developing a portfolio of immuno-oncology candidates, including checkpoint modulators (CPMs), heat shock protein vaccines, and adjuvants. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback